DNA/RNA based Diagnostics

Reliance Life Sciences provides DNA/RNA based diagnostics services for infectious diseases, qualitative tests for detection and quantitative assessment of the viral/bacterial load of infectious agents, including HIV and associated organisms like HCV, HBV, TB and CMV, using PCR, PCR-Sequencing (for genotyping) and Real Time PCR for precise quantification of viral and bacterial load, as also for expression analysis.

Specialised PCR testing is also provided for HLA typing, exon deletions for Duchenne Muscular Dystropy, Mitochondrial mutations for associated neurological diseases, Beta Thallasemia mutations for globin gene and Y chromosome deletion for male infertility investigations.

Reliance Life Sciences has ongoing research programs on Genotype-phenotype correlations in several cancers of significance in the Indian context, including oral cancer, breast cancer, cervical cancer and colon cancer, with the ultimate goal of developing predictive markers in human cancers and understanding their molecular pathology. The group aims to define single nucleotide polymorphisms indicative of high risk related to cardiovascular disease and diabetic retinopathy and establish predictive diagnostics for cancers (breast, cervical, colon and oral).

To know more about the molecular diagnostics testing services available, click here.